| 2024-07-19 |
详情>>
股本变动：
变动后总股本35535.42万股
|
| 2024-07-19 |
详情>>
业绩披露：
2024年中报每股收益3.03美元,归母净利润10.72亿美元,同比去年增长38.10%
|
| 2024-07-18 |
财报披露：
美东时间 2024-07-18 盘后发布财报
|
| 2024-04-19 |
详情>>
业绩披露：
2024年一季报每股收益1.54美元,归母净利润5.45亿美元,同比去年增长53.36%
|
| 2024-03-08 |
股东大会：
将于2024-04-25召开股东大会
会议内容 ▼▲
- 1.To elect eleven members to the Board of Directors of the Company to serve until the 2025 Annual Meeting of Stockholders.
2.To consider and approve, on an advisory basis, the compensation of the Company’s Named Executive Officers as disclosed in the Proxy Statement.
3.To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.
4.To approve the amendment and restatement of the Amended and Restated 2010 Incentive Award Plan.
5.To approve the amendment and restatement of the Amended and Restated 2000 Employee Stock Purchase Plan
6.To consider and vote upon a stockholder proposal requesting a racial and gender pay gap report (Proposal No. 6), if properly presented at the Annual Meeting.
|
| 2024-01-31 |
详情>>
业绩披露：
2021年年报每股收益4.79美元,归母净利润17.05亿美元,同比去年增长60.72%
|
| 2024-01-31 |
详情>>
业绩披露：
2023年年报每股收益5.12美元,归母净利润17.98亿美元,同比去年增长35.98%
|
| 2023-10-20 |
详情>>
业绩披露：
2023年三季报(累计)每股收益3.40美元,归母净利润11.92亿美元,同比去年增长19.49%
|
| 2023-07-24 |
详情>>
业绩披露：
2023年中报每股收益2.21美元,归母净利润7.76亿美元,同比去年增长15.25%
|
| 2023-04-20 |
详情>>
业绩披露：
2023年一季报每股收益1.01美元,归母净利润3.55亿美元,同比去年增长-2.82%
|
| 2023-04-20 |
详情>>
业绩披露：
2022年一季报每股收益1.02美元,归母净利润3.66亿美元,同比去年增长-14.24%
|
| 2023-03-10 |
股东大会：
将于2023-04-27召开股东大会
会议内容 ▼▲
- 1.To elect eleven members to the Board of Directors of the Company to serve until the 2024 Annual Meeting of Stockholders (Proposal No. 1).
2.To consider and approve, on an advisory basis, the compensation of the Company’s Named Executive Officers as disclosed in the Proxy Statement (Proposal No. 2).
3.To consider and approve, on an advisory basis, the frequency of the advisory vote on the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement (Proposal No. 3)
4.To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 (Proposal No. 4).
5.To consider and vote upon a stockholder proposal regarding pay equity disclosure (Proposal No. 5), if properly presented at the Annual Meeting.
|
| 2023-03-10 |
股东大会：
将于2023-04-27召开股东大会
会议内容 ▼▲
- 1.To elect eleven members to the Board of Directors of the Company to serve until the 2024 Annual Meeting of Stockholders (Proposal No. 1).
2.To consider and approve, on an advisory basis, the compensation of the Company’s Named Executive Officers as disclosed in the Proxy Statement (Proposal No. 2).
3.To consider and approve, on an advisory basis, the frequency of the advisory vote on the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement (Proposal No. 3)
4.To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 (Proposal No. 4).
5.To consider and vote upon a stockholder proposal regarding pay equity disclosure (Proposal No. 5), if properly presented at the Annual Meeting.
|
| 2023-02-10 |
详情>>
业绩披露：
2022年年报每股收益3.72美元,归母净利润13.22亿美元,同比去年增长-22.43%
|
| 2022-10-21 |
详情>>
业绩披露：
2022年三季报(累计)每股收益2.79美元,归母净利润9.97亿美元,同比去年增长-24.67%
|
| 2022-07-22 |
详情>>
业绩披露：
2022年中报每股收益1.88美元,归母净利润6.73亿美元,同比去年增长-28.63%
|
| 2022-03-09 |
股东大会：
将于2022-04-28召开股东大会
会议内容 ▼▲
- 1.To elect eleven members to the Board of Directors of the Company to serve until the 2023 Annual Meeting of Stockholders.
2.To consider and approve, on an advisory basis, the compensation of the Company’s Named Executive Officers (“NEOs”) as disclosed in the Proxy Statement.
3.To ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.
4.To approve the amendment and restatement of the Amended and Restated 2010 Incentive Award Plan.
5.To transact any other business that is properly brought before the Annual Meeting or adjournments or postponements thereof.
|
| 2021-10-05 |
详情>>
拆分方案：
每1.0000股拆分成3.0000股
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-19 |
股东大会：
将于2021-09-20召开股东大会
|
| 2021-03-10 |
股东大会：
将于2021-04-22召开股东大会
会议内容 ▼▲
- 1.To elect eleven members to the Board of Directors of the Company to serve until the 2022 Annual Meeting of Stockholders (Proposal No. 1).
2.To consider and approve, on an advisory basis, the compensation of the Company’s Named Executive Officers (“NEOs”) as disclosed in the Proxy Statement (Proposal No. 2).
3.To ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 (Proposal No. 3).
4.To approve the amendment and restatement of the Amended and Restated 2010 Incentive Award Plan (Proposal No. 4).
5.To transact any other business that is properly brought before the Annual Meeting or adjournments or postponements thereof.
|
| 2020-03-13 |
股东大会：
将于2020-04-23召开股东大会
会议内容 ▼▲
- 1.To elect ten members to the Board of Directors of the Company to serve until the 2021 Annual Meeting of Stockholders (Proposal No. 1).
2.To consider and approve, on an advisory basis, the compensation of the Company’s Named Executive Officers (“NEOs”) as disclosed in the Proxy Statement (Proposal No. 2).
3.To ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020 (Proposal No. 3).
4.To approve the amendment and restatement of the Amended and Restated 2010 Incentive Award Plan (Proposal No. 4).
5.To approve the amendment of our Amended and Restated Certificate of Incorporation to adopt simple majority voting provisions (Proposal No. 5).
6.To approve the amendment of our Amended and Restated Certificate of Incorporation to permit stockholders to call a special meeting (Proposal No. 6).
7.To transact any other business that is properly brought before the Annual Meeting or adjournments or postponements thereof.
|
| 2019-03-08 |
股东大会：
将于2019-04-25召开股东大会
会议内容 ▼▲
- 1.To elect nine members to the Board of Directors of the Company to serve until the 2020 Annual Meeting of Stockholders (Proposal No. 1).
2.To consider and approve, on an advisory basis, the compensation of the Company’s Named Executive Officers (“NEOs”) as disclosed in the Proxy Statement (Proposal No. 2).
3.To ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019 (Proposal No. 3).
4.To approve the amendment and restatement of the 2010 Incentive Award Plan (Proposal No. 4).
5.To consider and vote upon a stockholder proposal regarding elimination of supermajority voting provisions, (Proposal No. 5), if properly presented at the Annual Meeting.
6.To transact any other business which is properly brought before the Annual Meeting or adjournments or postponements thereof.
|
| 2018-07-23 |
详情>>
内部人交易：
Friedman Michael A股份增加975.00股
|
| 2018-03-02 |
股东大会：
将于2018-04-19召开股东大会
会议内容 ▼▲
- 1. to elect nine members to the Board of Directors of the Company to serve until the 2019 Annual Meeting of Stockholders (Proposal No. 1);
2. to consider and approve, on an advisory basis, the compensation of the Company's Named Executive Officers (“NEOs”) as disclosed in the Proxy Statement (Proposal No. 2);
3. to ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018 (Proposal No. 3);
4. to transact any other business which is properly brought before the Annual Meeting or adjournments or postponements thereof.
|
| 2017-08-25 |
股东大会：
将于2017-09-22召开股东大会
|
| 2017-08-11 |
详情>>
拆分方案：
每1.0000股拆分成3.0000股
|
| 2017-03-03 |
股东大会：
将于2017-04-20召开股东大会
会议内容 ▼▲
- 1.to elect nine members to the Board of Directors of the Company to serve until the 2018 Annual Meeting of Stockholders;
2.to consider and approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement (“NEOs”);
3.to vote, on an advisory basis, on the frequency of the advisory vote on the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement;
4.to ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017;
5.to approve the amendment and restatement of the 2000 Employee Stock Purchase Plan;
6.to approve the amendment and restatement of the 2010 Incentive Award Plan;
7.to transact any other business which is properly brought before the Annual Meeting or adjournments or postponements thereof.
|
| 2016-03-07 |
股东大会：
将于2016-04-21召开股东大会
会议内容 ▼▲
- 1.to elect nine members to the Board of Directors of the Company to serve until the 2017 Annual Meeting of Stockholders;
2.to consider and approve, on an advisory basis, the compensation of our Named Executive Officers as disclosed in the Proxy Statement ("NEOs");
3.to ratify the appointment of PricewaterhouseCoopers LLP ("PwC") as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016;
4.to approve the amendment and restatement of the 2010 Incentive Award Plan;
5.to transact any other business which is properly brought before the Annual Meeting or adjournments or postponements thereof.
|
| 2015-03-06 |
股东大会：
将于2015-04-23召开股东大会
会议内容 ▼▲
- 1.to elect eight members to the Board of Directors (the “Board”) to serve until the 2016 Annual Meeting of Stockholders;
2.to consider an advisory vote on the approval of the compensation of our named executive officers ("NEOs");
3.to ratify the appointment of PricewaterhouseCoopers LLP ("PwC") as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015;
4.to approve the amendment and restatement of the 2010 Incentive Award Plan;
5.to transact any other business which is properly brought before the Annual Meeting or adjournments or postponements thereof.
|